Premium
Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy
Author(s) -
Racil Zdenek,
Toskova Martina,
Dvorakova Dana,
Jeziskova Ivana,
Razga Filip,
Buresova Lucie,
Timilsina Shira,
Mayer Jiri
Publication year - 2012
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.22213
Subject(s) - clofarabine , medicine , myeloid leukemia , oncology , minimal residual disease , transplantation , acute promyelocytic leukemia , refractory (planetary science) , salvage therapy , leukemia , cytarabine , chemotherapy , gene , biology , retinoic acid , biochemistry , astrobiology
Few studies have examined the treatment of molecular relapse in patients with acute myeloid leukemia (AML) using different treatment regimens. We describe for the first time in the literature experiences with administration of clofarabine monotherapy in the treatment of eight patients with AML with molecular relapse of the disease.